NCT02193061View on ClinicalTrials.gov

Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs

PHASE3CompletedINTERVENTIONAL
Enrollment

1,498

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

November 30, 2017

Conditions
Rotavirus Vaccine
Interventions
BIOLOGICAL

Rotarix

BIOLOGICAL

RotaTeq

Trial Locations (1)

04530

National Instiute of Pediatrics, México

All Listed Sponsors
collaborator

Centro Nacional para la Salud de la Infancia y la Adolescencia

OTHER_GOV

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

National Institute of Pediatrics, Mexico

OTHER_GOV

NCT02193061 - Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs | Biotech Hunter | Biotech Hunter